Self-Regulation Of The Immune System Suppresses Defense Against Cancer
1/01/2012
It is vital that the body's own immune system does not overreact. If its key players, the helper T cells, get out of control, this can lead to autoimmune diseases or allergies. An immune system overreaction against infectious agents may even directly damage organs and tissues...
FDA To Review Potential New Use Of XGEVA® (Denosumab) At Oncologic Drugs Advisory Committee Meeting
12/31/2011
Amgen (NASDAQ: AMGN) announced the U.S. Food and Drug Administration (FDA) has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA® (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases...
A team of cancer imaging experts at Johns Hopkins has embarked on a five-year research initiative to speed development of early diagnostic tests and new treatments for breast, prostate and other common cancers...
A team of cancer imaging experts at Johns Hopkins has embarked on a five-year research initiative to speed development of early diagnostic tests and new treatments for breast, prostate and other common cancers...
Ovarian Cancer Study Proves Drug Delays Disease Progression, May Improve Survival
12/29/2011
Treating ovarian cancer with the drug bevacizumab ("Avastin") delays the disease and may also improve survival, show the results of an international clinical trial co-led by Drs. Amit Oza of the Princess Margaret Cancer Program, University Health Network and Timothy Perren, St James's Institute of Oncology, Leeds, UK...
Ovarian Cancer Study Proves Drug Delays Disease Progression, May Improve Survival
12/29/2011
Treating ovarian cancer with the drug bevacizumab ("Avastin") delays the disease and may also improve survival, show the results of an international clinical trial co-led by Drs. Amit Oza of the Princess Margaret Cancer Program, University Health Network and Timothy Perren, St James's Institute of Oncology, Leeds, UK...
Key Genetic Error Found In Family Of Blood Cancers
12/29/2011
Scientists have uncovered a critical genetic mutation in some patients with myelodysplastic syndromes - a group of blood cancers that can progress to a fatal form of leukemia. The research team at Washington University School of Medicine in St. Louis also found evidence that patients with the mutation are more likely to develop acute leukemia...
Targeted Blocking Of Cell Death Prevents Fatal Condition Septic Shock
12/29/2011
Researchers of VIB and UGent have discovered a new approach to preventing septic shock, an often fatal extreme inflammatory reaction of the body. It is the most frequent cause of death at intensive care departments in hospitals. In sepsis, acute inflammation is attended by low blood pressure and blood clots, causing the organs to stop working...
Futuristic Therapy: Steering Microrobots Through Blood Vessels For Disease Treatment
12/29/2011
Microscopic-scale medical robots represent a promising new type of therapeutic technology. As envisioned, the microbots, which are less than one millimeter in size, might someday be able to travel throughout the human bloodstream to deliver drugs to specific targets or seek out and destroy tumors, blood clots, and infections that can't be easily accessed in other ways...
State Will Pay For PIP Breast Implant Removal, Says Venezuelan Health Minister
12/28/2011
Venezuelan Health Minister, Eugenia Sader, has announced that the full costs of removing the Poly Implant Prothèses (PIP) breast implants will be covered by the state. Ms. Sader emphasized that this offer stands for any woman who wishes to have them removed. French authorities have also offered to cover the full costs...